Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

SEVOFLURANE 99.97 %

SEVOFLURANE : 99.97 % · DIN 02307766 · PIRAMAL CRITICAL CARE INC

Health Canada status: MARKETED

What is SEVOFLURANE?

SEVOFLURANE 99.97 % contains SEVOFLURANE : 99.97 %. It is listed in the Health Canada Drug Product Database under DIN 02307766, held by PIRAMAL CRITICAL CARE INC, supplied as LIQUID for INHALATION administration. Health Canada currently lists it as marketed, status dated 27-Jun-2022. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

What is SEVOFLURANE used for?

Induction and maintenance of general anesthesia in adult and pediatric patients for inpatient and outpatient surgery.

Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.

Product details and regulatory record

DIN02307766
Brand nameSEVOFLURANE
Generic / active ingredientSEVOFLURANE : 99.97 %
ManufacturerPIRAMAL CRITICAL CARE INC
Strength99.97 %
Dosage formLIQUID
Route of administrationINHALATION
SchedulePrescription
ATC codeN01AB08 SEVOFLURANE
AHFS class28:04.16
BiosimilarNo
Health Canada statusMARKETED
Status date27-Jun-2022
Original market date2009-11-18 00:00:00

How is it administered?

Individually titrated. Induction: Mask induction suitable. Maintenance: 0.5% to 3% with or without nitrous oxide. Minimum fresh gas flow of 2 L/min recommended.

Included because it drives pack selection and wastage. Consult the monograph.

How is it stored and handled?

Store at 15-30°C. Keep cap tightly closed. Avoid desiccated CO2 absorbents.

How is it supplied?

250 mL amber colored glass bottles with a screw cap or integrated closure.

Contraindications

Known sensitivity to sevoflurane or halogenated anesthetics; history of liver dysfunction/unexplained fever after previous administration; known/suspected genetic susceptibility to malignant hyperthermia.

Warnings and precautions

Administer only by trained professionals. Risk of malignant hyperthermia, perioperative hyperkalemia, QT prolongation, and seizures. Avoid desiccated CO2 absorbents (fire/heat risk).

What can be used instead?

Other Canadian products sharing ATC code N01AB08 SEVOFLURANE. 3 of 4 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.

ProductStrengthFormManufacturerHealth Canada statusDIN
SEVOFLURANE99.97 %LIQUIDBAXTER CORPORATIONMARKETEDDIN 02265974
SEVORANE AF99.97 %LIQUIDABBVIE CORPORATIONMARKETEDDIN 02172763
SEVOFLURANE99.9875 %LIQUIDBLUE-ZONE TECHNOLOGIES LTDAPPROVEDDIN 02553449

Who else supplies SEVOFLURANE worldwide?

Nexara tracks national medicine registries and published price lists across multiple markets. SEVOFLURANE appears in 687 registered pack listings across 9 markets, published on 7 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.

Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.

How can I get it?

Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.

Request a quote for SEVOFLURANE

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Request a quote for SEVOFLURANE

Health Canada Drug Product Database (DPD), DIN 02307766. Last reviewed 2026-09-08. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.